Bruce Jackson
Stock Analyst at Benchmark
(1.01)
# 3,680
Out of 4,876 analysts
123
Total ratings
28.46%
Success rate
-21.38%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.62 | +340.07% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $2.22 | +530.63% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.51 | +486.05% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $3.92 | +741.84% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $3.05 | +654.10% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $59.90 | +33.56% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $7.16 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $51.81 | +25.46% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.87 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $30 | $5.94 | +405.05% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.76 | +64.47% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.17 | +156.41% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.34 | +113.68% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.72 | +4,092.87% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $3.37 | +1,680.42% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.36 | +4,648.60% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.92 | +2,508.70% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $1.89 | -47.09% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.65 | +670.42% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.94 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $16.81 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.84 | +20,733.33% | 1 | Aug 8, 2022 |
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.62
Upside: +340.07%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $2.22
Upside: +530.63%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.51
Upside: +486.05%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $3.92
Upside: +741.84%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $3.05
Upside: +654.10%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $59.90
Upside: +33.56%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.16
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $51.81
Upside: +25.46%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.87
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $5.94
Upside: +405.05%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.76
Upside: +64.47%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.17
Upside: +156.41%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.34
Upside: +113.68%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.72
Upside: +4,092.87%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $3.37
Upside: +1,680.42%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.36
Upside: +4,648.60%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.92
Upside: +2,508.70%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $1.89
Upside: -47.09%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.65
Upside: +670.42%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.94
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $16.81
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.84
Upside: +20,733.33%